Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 140.55
-0.481 %
$ 20.5 B
Market Cap
12.72
P/E
BIIB - CAPITAL EXPENDITURES
Capital Expenditures BIIB - Biogen Inc.
-311 M
LAST VALUE
-2.76%
2 YEAR CAGR
18.87%
5 YEAR CAGR
21.51%
10 YEAR CAGR